Dr. Reddy's Opens Trial Over Major Diabetes Treatment Patents
Counsel for generic drugmaker Dr. Reddy's urged a London court Monday to invalidate patent protections for Boehringer Ingelheim's billion-dollar diabetes treatment, in a bid to clear the way for its own...To view the full article, register now.
Already a subscriber? Click here to view full article